A novel application of t‐statistics to objectively assess the quality of IC50 fits for P‐glycoprotein and other transporters. Issue 1 (2nd December 2014)
- Record Type:
- Journal Article
- Title:
- A novel application of t‐statistics to objectively assess the quality of IC50 fits for P‐glycoprotein and other transporters. Issue 1 (2nd December 2014)
- Main Title:
- A novel application of t‐statistics to objectively assess the quality of IC50 fits for P‐glycoprotein and other transporters
- Authors:
- O'Connor, Michael
Lee, Caroline
Ellens, Harma
Bentz, Joe - Abstract:
- <abstract abstract-type="main" id="prp278-abs-0001"> <title>Abstract</title> <p>Current USFDA and EMA guidance for drug transporter interactions is dependent on IC<sub>50</sub> measurements as these are utilized in determining whether a clinical interaction study is warranted. It is therefore important not only to standardize transport inhibition assay systems but also to develop uniform statistical criteria with associated probability statements for generation of robust IC<sub>50</sub> values, which can be easily adopted across the industry. The current work provides a quantitative examination of critical factors affecting the quality of IC<sub>50</sub> fits for P‐gp inhibition through simulations of perfect data with randomly added error as commonly observed in the large data set collected by the P‐gp IC<sub>50</sub> initiative. The types of errors simulated were (1) variability in replicate measures of transport activity; (2) transformations of error‐contaminated transport activity data prior to IC<sub>50</sub> fitting (such as performed when determining an IC<sub>50</sub> for inhibition of P‐gp based on efflux ratio); and (3) the lack of well defined "no inhibition" and "complete inhibition" plateaus. The effect of the algorithm used in fitting the inhibition curve (e.g., two or three parameter fits) was also investigated. These simulations provide strong quantitative support for the recommendations provided in Bentz et al. (<xref ref-type="link"<abstract abstract-type="main" id="prp278-abs-0001"> <title>Abstract</title> <p>Current USFDA and EMA guidance for drug transporter interactions is dependent on IC<sub>50</sub> measurements as these are utilized in determining whether a clinical interaction study is warranted. It is therefore important not only to standardize transport inhibition assay systems but also to develop uniform statistical criteria with associated probability statements for generation of robust IC<sub>50</sub> values, which can be easily adopted across the industry. The current work provides a quantitative examination of critical factors affecting the quality of IC<sub>50</sub> fits for P‐gp inhibition through simulations of perfect data with randomly added error as commonly observed in the large data set collected by the P‐gp IC<sub>50</sub> initiative. The types of errors simulated were (1) variability in replicate measures of transport activity; (2) transformations of error‐contaminated transport activity data prior to IC<sub>50</sub> fitting (such as performed when determining an IC<sub>50</sub> for inhibition of P‐gp based on efflux ratio); and (3) the lack of well defined "no inhibition" and "complete inhibition" plateaus. The effect of the algorithm used in fitting the inhibition curve (e.g., two or three parameter fits) was also investigated. These simulations provide strong quantitative support for the recommendations provided in Bentz et al. (<xref ref-type="link" rid="prp278-bib-0005">2013</xref>) for the determination of IC<sub>50</sub> values for P‐gp and demonstrate the adverse effect of data transformation prior to fitting. Furthermore, the simulations validate uniform statistical criteria for robust IC<sub>50</sub> fits in general, which can be easily implemented across the industry. A calibration of the <italic>t</italic>‐statistic is provided through calculation of confidence intervals associated with the <italic>t</italic>‐statistic.</p> </abstract> … (more)
- Is Part Of:
- Pharmacology research & perspectives. Volume 3:Issue 1(2015:Feb.)
- Journal:
- Pharmacology research & perspectives
- Issue:
- Volume 3:Issue 1(2015:Feb.)
- Issue Display:
- Volume 3, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 3
- Issue:
- 1
- Issue Sort Value:
- 2015-0003-0001-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2014-12-02
- Subjects:
- Pharmacology -- Periodicals
Drug development -- Periodicals
615.105 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2052-1707 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/prp2.78 ↗
- Languages:
- English
- ISSNs:
- 2052-1707
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3431.xml